TY - JOUR PY - 2019 J2 - Chem. Eng. Sci. SN - 0009-2509 T2 - Chemical Engineering Science VL - 201 DO - 10.1016/j.ces.2019.02.019 TI - Crystallization of fesoterodine fumarate active pharmaceutical ingredient: Modelling of thermodynamic equilibrium, nucleation, growth, agglomeration and dissolution kinetics and temperature cycling UR - https://www.cheric.org/research/tech/periodicals/view.php?seq=1721286 KW - Fesoterodine fumarate ingredient KW - Crystallization KW - Dissolution KW - Consecutive temperature cycling KW - Mathematical process modelling KW - Population balance equation AU - Trampuz M AU - Teslic D AU - Likozar B SP - 97 EP - 111 LA - English ER -